Figure 3From: CpG increases vaccine antigen-specific cell-mediated immunity when administered with hepatitis B vaccine in HIV infectionProliferative responses to HIV p24 antigen. Proliferative response to HIV p24 Ag evaluated as A) cpm or B) SI, did not change over the 48 week study period in either subjects that received hepatitis B vaccine plus CpG (solid line; n = 19) or those that received hepatitis B vaccine without CpG (broken line; n = 19).Back to article page